University Hospital Tübingen, Institute of Tropical Medicine
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Esen, Meral
NCT05389319: A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

Suspended
1
60
Europe
Prime-2-CoV_Beta
University Hospital Tuebingen, FGK Clinical Research GmbH, VisMederi srl, Staburo GmbH, Viedoc Technologies AB
COVID-19
01/25
12/25
NCT06124144: Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Terminated
1
13
Europe
Oleylphosphocholine, OlPC
University Hospital Tuebingen
Leishmaniasis
02/24
02/24
HELMVIT, NCT04324853: Helminth Infection During Pregnancy on Vitamin D Regulation: Study

Completed
N/A
180
RoW
Microscopy ( Urine filtration), UCAA test, qPCR,, Microscopy (Kato Katz, Coproculture, Harada Mori, MIF), qPCR,
Centre de Recherche Médicale de Lambaréné, Technical University of Munich, University Hospital Tuebingen
Vitamin D Deficiency, Immunosuppression
12/22
12/22

Download Options